WallStreetZenWallStreetZen

NASDAQ: CADL
Candel Therapeutics Inc Stock Ownership - Who owns Candel Therapeutics?

OverviewForecastEarningsRevenueDividendOwnership

Insider buying vs selling

Have Candel Therapeutics Inc insiders been buying or selling?

Buy
Sell
NameRoleDateSharesPriceValue
Paul Peter TakCEO2026-09-1159,379$10.46
$620.87kSell
Paul Peter TakCEO2026-09-10125,000$1.55
$193.75kBuy
Paul Peter TakCEO2026-09-10220,866$11.50
$2.54MSell
Seshu TyagarajanCTO2026-08-177,000$12.00
$84.00kSell
Francesca BaroneChief Scientific Officer2026-06-2923,447$10.06
$235.76kSell
Seshu TyagarajanChief Technology Officer2026-06-297,000$10.02
$70.15kSell
Paul B. ManningDirector2026-02-23550,458$5.45
$3.00MBuy

1 of 1

CADL insiders have bought more... subscribe to Premium to read more.
Net Insider Buy/Sell (L12M) Ownership

Be the first to know when CADL insiders and whales buy or sell their stock.

CADL Shareholders

What type of owners hold Candel Therapeutics Inc stock?

Institutional
Insider
Retail
NameHoldSharesValueType
Estuardo Aguilarcordova9.35%7,156,946$58.11MInsider
Paul B. Manning7.51%5,748,279$46.68MInsider
Laura K. Aguilar3.98%3,046,940$24.74MInsider
Christopher Martell0.91%698,863$5.67MInsider
Jason Amello0.26%202,009$1.64MInsider
Paul Peter Tak0.15%113,321$920.17kInsider
Joseph C. Papa0.13%102,271$830.44kInsider
Francesca Barone0.10%77,362$628.18kInsider
Seshu Tyagarajan0.10%76,865$624.14kInsider
William Garrett Nichols0.07%52,493$426.24kInsider

1 of 3

CADL vs Biotech Stocks

TickerInst. %Insider %Net Insider (L12M)Net Insider (L3M)
CADL0.07%22.78%Net BuyingNet Selling
SLDB0.11%61.44%Net SellingNet Selling
SLBT0.00%60.21%Net BuyingNet Buying
FDMT0.11%22.42%Net SellingNet Selling
ACHV0.08%16.79%Net SellingNet Selling
View Top Biotech Stocks

Candel Therapeutics Stock Ownership FAQ

Who owns Candel Therapeutics?

Candel Therapeutics (NASDAQ: CADL) is owned by 0.07% institutional shareholders, 22.78% Candel Therapeutics insiders, and 77.15% retail investors. Estuardo Aguilarcordova is the largest individual Candel Therapeutics shareholder, owning 7.16M shares representing 9.35% of the company. Estuardo Aguilarcordova's Candel Therapeutics shares are currently valued at $63.12M.

If you're new to stock investing, here's how to buy Candel Therapeutics stock.
©2026 WallStreetZen
Company
AboutNewsBlogStock Investing FAQPlansPrivacy PolicyTerms of ServiceCancellation & RefundsPerformanceHelp GuidesContactTwitterYouTubeNewsletter
Stock Tools
Top Performing AnalystsStock ScreenerStock ForecastTrending StocksStrong Buy StocksHighest Earnings StocksBest Dividend Paying StocksStatisticsStock Market SectorsStock Market IndustriesHow to Buy Stocks Online
Stock Ideas
Buy The DipBiggest Stock Gainers TodayBiggest Stock Losers Today52 Week High Stocks52 Week Low StocksMost Active Stocks TodayMost Undervalued StocksBest Penny Stocks to Buy NowBest Stocks Under $5Best Stocks Under $10
WallStreetZen does not provide financial advice and does not issue recommendations or offers to buy stock or sell any security.

Information is provided 'as-is' and solely for informational purposes and is not advice. WallStreetZen does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.